The ACO Show

Josh and Brian are joined by Aledade’s Chief Financial Officer, John Doyle. John provides a brief recap on the recent J.P. Morgan Healthcare Conference, how Aledade’s alignment as a company drew him in, and the many factors companies take into consideration before going public.

Josh and Brian are joined by Aledade’s CEO and co-founder, Dr. Farzad Mostashari, and Amy Simmerman, a partner at Wilson Sonsini Goodrich & Rosati, to discuss the idea of a public benefit corporation - what it is and what it means, why Aledade has decided to become one, and what this means for the health care industry as a whole.

Value-based care is often more focused on adults, especially the elderly who have the most burden of illness and, on average, the highest health care costs. Josh is joined by Dr. Karin McLelland, a pediatrician in North Carolina, and Carissa Praytor, Manager of Medicaid Performance at Aledade, to discuss how Aledade’s pediatric ACO in North Carolina was able to enable more primary care and reduce costs for this often-overlooked population of our nation’s youngest patients.

Josh and Brian are joined by Dr. Sarah Mullins, co-owner of Stoney Batter Family Medicine in Wilmington, Delaware, and Senior Regional Medical Director at Aledade, to discuss the role of care management programs in value-based care, how to build and sustain them, and the value they provide to patients and practices.

Josh and Brian are joined by Mike Stanzione, Aledade’s Director of Medicare Advantage Network Performance, to discuss the state of Medicare Advantage (MA), its rapid growth, regulatory evolution, and how the Aledade model of care applies to MA.

Josh and Brian are joined by Dr. Asaf Bitton, executive director of Ariadne Labs, and Associate Professor of Medicine and Health Care Policy at Harvard Medical School and the Harvard T.H. Chan School of Public Health. They discuss the need to move to value-based care and change the payment structure. They also reflect on the historical underfunding and undervaluing of primary care.

Josh and Brian are joined by Dan Bowles, Aledade’s Chief Growth Officer, to discuss the state of the value-based care landscape and how to distinguish the various models fellow travelers are implementing in the space.

Josh and Brian are joined by Dr. Mandy Cohen, CEO of Aledade Care Solutions, to discuss the importance of the trust she and her team built with communities in North Carolina during the COVID-19 pandemic and how that parallels building trust with physicians and management organizations in the value-based care movement. They also talk about how Aledade Care Solutions has evolved as a direct-to-patient arm of Aledade’s portfolio with the goal of adding additional resources to improve patient outcomes.

Josh (@DrJIsrael) is joined by Bijan Salhizadeh (@bijans), Managing Director at NaviMed Capital, to discuss the current state of healthcare stocks and factors that affect IPO valuation for companies hoping to go public.

Josh (@DrJIsrael) and Brian (@chiglinsky) are joined by Chelsea Graves, Aledade’s Director of Medicaid Performance, to discuss factors that affect healthcare access and outcomes for vulnerable populations. Chelsea also shares the secrets behind the success of Aledade’s recent collaboration with the Community Health Center Association of Mississippi (CHCAMS) to serve the Medicaid population and improve their access to primary care.